• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Dexcom, RxFood partner on AI-based nutrition, glucose monitoring for diabetes management

September 22, 2023 By Sean Whooley

Dexcom RxFood CGM data
Within the RxFood app, Dexcom CGM users can capture photos of their meals. It eliminates the need for manual food and nutrition tracking. [Image courtesy of RxFood/Dexcom]
Dexcom (Nasdaq:DXCM) announced that it teamed up with RxFood on a digital diabetes solution for people in Canada.

The first-of-its-kind partnership combines Dexcom’s continuous glucose monitoring (CGM) with RxFood’s AI-driven personalized nutrition assessments. The companies aim to introduce an improved digital health solution for people living with diabetes. It integrates food data with insulin dosing, exercise and glucose information.

RxFood made its next-generation app, featuring Dexcom CGM data integration, now available to healthcare program stakeholders in Canada. That includes clinics, hospitals, health authorities, pharmacies, insurers and employers. Through these programs, Canadians using the Dexcom G6 or G7 (once available) can access combined food and glucose data. It offers a more comprehensive personalized understanding of their health and glucose control.

“At Dexcom, introducing industry-leading technology that transforms day-to-day diabetes management for users around the world has been our primary goal for over two decades,” said André Côté, VP and GM, Dexcom Canada. “Working closely with RxFood on this innovative solution has allowed us to advance this even further. We look forward to demonstrating how our partnership will help continue to simplify diabetes management for individuals and families, providing deep, actionable nutritional insights to enhance overall health.”

More about the integration between Dexcom and RxFood

Within the app, Dexcom CGM users can capture photos of meals to eliminate the need for manual food and nutrition tracking. As they photo-log, RxFood continuously generates detailed diet quality metrics to combine with glucose data.

The combination addresses the need for unified, time-matched food and glucose data reports, the companies said. This helps users effectively manage diabetes and enables personalized nutritional guidance at scale.

RxFood’s app demonstrated its efficacy through a three-year clinical trial focused on the families of children with diabetes. It demonstrated improved accuracy in carbohydrate counting, a decrease in counting errors exceeding 10g and lower A1C levels.

Additionally, Dexcom and RxFood say that, as adoption rose in Canada, the app helped reduce the time associated with day-to-day diabetes management. It gave clinicians more complete food records, too, supporting more personalized care recommendations.

“Continuous glucose monitoring is a key component of diabetes management, but food type, amount, and timing are also important variables. By seamlessly integrating food data with insulin dosing, exercise, and glucose information, a comprehensive understanding of how specific food items impact glucose levels is made possible,” said Dr. Jeffrey Alfonsi, chief medical officer at RxFood. “These invaluable insights empower both patients and clinicians to enhance diabetes management by identifying and addressing factors that contribute to glucose excursions, leading to improved overall control and care.”

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Dexcom

IN CASE YOU MISSED IT

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • LifePlus reports clinical validation of non-invasive glucose, blood pressure monitor
  • Abbott Diabetes head talks Medtronic partnership, exciting times ahead
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS